Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 13 studies | 22% ± 7% | |
classical monocyte | 7 studies | 21% ± 6% | |
non-classical monocyte | 5 studies | 27% ± 10% | |
myeloid cell | 3 studies | 24% ± 2% | |
epithelial cell | 3 studies | 23% ± 4% | |
monocyte | 3 studies | 23% ± 7% | |
dendritic cell | 3 studies | 26% ± 8% |
Insufficient scRNA-seq data for expression of RNF135 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 2113.66 | 1809 / 1809 | 100% | 39.05 | 472 / 472 |
thymus | 100% | 1716.01 | 653 / 653 | 100% | 46.60 | 605 / 605 |
prostate | 100% | 1473.36 | 245 / 245 | 100% | 40.27 | 501 / 502 |
uterus | 100% | 1415.85 | 170 / 170 | 100% | 35.46 | 458 / 459 |
kidney | 100% | 1658.42 | 89 / 89 | 100% | 51.38 | 899 / 901 |
breast | 100% | 1931.95 | 459 / 459 | 100% | 54.42 | 1114 / 1118 |
esophagus | 100% | 1544.89 | 1445 / 1445 | 99% | 29.76 | 182 / 183 |
intestine | 100% | 1405.72 | 966 / 966 | 99% | 31.16 | 524 / 527 |
bladder | 100% | 1500.38 | 21 / 21 | 99% | 38.31 | 501 / 504 |
lung | 100% | 1686.69 | 576 / 578 | 99% | 38.73 | 1149 / 1155 |
ovary | 100% | 1188.48 | 180 / 180 | 99% | 30.23 | 426 / 430 |
stomach | 99% | 945.73 | 357 / 359 | 99% | 28.13 | 283 / 286 |
pancreas | 98% | 738.49 | 322 / 328 | 98% | 33.42 | 175 / 178 |
adrenal gland | 100% | 1288.86 | 257 / 258 | 91% | 17.16 | 209 / 230 |
brain | 84% | 375.62 | 2224 / 2642 | 79% | 18.73 | 559 / 705 |
liver | 69% | 315.22 | 155 / 226 | 39% | 7.49 | 159 / 406 |
adipose | 100% | 2018.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 35.66 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 40.73 | 29 / 29 |
spleen | 100% | 2655.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 34.57 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 37.99 | 1 / 1 |
blood vessel | 100% | 1252.88 | 1332 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2084.10 | 919 / 929 | 0% | 0 | 0 / 0 |
heart | 92% | 509.60 | 788 / 861 | 0% | 0 | 0 / 0 |
muscle | 81% | 376.96 | 647 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051260 | Biological process | protein homooligomerization |
GO_0016567 | Biological process | protein ubiquitination |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0045087 | Biological process | innate immune response |
GO_0010994 | Biological process | free ubiquitin chain polymerization |
GO_0045088 | Biological process | regulation of innate immune response |
GO_0039529 | Biological process | RIG-I signaling pathway |
GO_0070534 | Biological process | protein K63-linked ubiquitination |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0043021 | Molecular function | ribonucleoprotein complex binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0039552 | Molecular function | RIG-I binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | RNF135 |
Protein name | Ring finger protein 135 E3 ubiquitin-protein ligase RNF135 (EC 2.3.2.27) (RIG-I E3 ubiquitin ligase) (REUL) (RING finger protein 135) (RING finger protein leading to RIG-I activation) (Riplet) (RING-type E3 ubiquitin transferase RNF135) |
Synonyms | L13 |
Description | FUNCTION: E2-dependent E3 ubiquitin-protein ligase that functions as a RIGI coreceptor in the sensing of viral RNAs in cell cytoplasm and the activation of the antiviral innate immune response . Together with the UBE2D3, UBE2N and UB2V1 E2 ligases, catalyzes the 'Lys-63'-linked polyubiquitination of RIGI oligomerized on viral RNAs, an essential step in the activation of the RIG-I signaling pathway . Through a ubiquitin-independent parallel mechanism, which consists in bridging RIGI filaments forming on longer viral RNAs, further activates the RIG-I signaling pathway . This second mechanism that synergizes with the ubiquitin-dependent one would thereby allow an RNA length-dependent regulation of the RIG-I signaling pathway (Probable). Associated with the E2 ligase UBE2N, also constitutively synthesizes unanchored 'Lys-63'-linked polyubiquitin chains that may also activate the RIG-I signaling pathway . . |
Accessions | ENST00000443677.6 ENST00000324689.8 [Q8IUD6-2] ENST00000708425.1 [Q8IUD6-2] ENST00000708427.1 [Q8IUD6-3] ENST00000708426.1 [Q8IUD6-1] H7C3H8 ENST00000434242.2 Q8IUD6 ENST00000580444.2 J3QS68 ENST00000535306.6 [Q8IUD6-3] K7EQF1 ENST00000328381.10 [Q8IUD6-1] |